{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T11:55:54Z","timestamp":1793361354021,"version":"4.5.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI07140"],"award-info":[{"award-number":["AI07140"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI127563"],"award-info":[{"award-number":["R01AI127563"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TR002317"],"award-info":[{"award-number":["TR002317"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Innate immunity and type 1 interferon (IFN) defenses are critical for early control of HIV infection within CD4\u2009+\u2009T cells. Despite these defenses, some acutely infected cells silence viral transcription to become latently infected and form the HIV reservoir in vivo. Latently infected cells persist through antiretroviral therapy (ART) and are a major barrier to HIV cure. Here, we evaluated innate immunity and IFN responses in multiple T cell models of HIV latency, including established latent cell lines, Jurkat cells latently infected with a reporter virus, and a primary CD4\u2009+\u2009T cell model of virologic suppression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found that while latently infected T cell lines have functional RNA sensing and IFN signaling pathways, they fail to induce specific interferon-stimulated genes (ISGs) in response to innate immune activation or type 1 IFN treatment. Jurkat cells latently infected with a fluorescent reporter HIV similarly demonstrate attenuated responses to type 1 IFN. Using bulk and single-cell RNA sequencing we applied a functional genomics approach and define ISG expression dynamics in latent HIV infection, including HIV-infected ART-suppressed primary CD4\u2009+\u2009T cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our observations indicate that HIV latency and viral suppression each link with cell-intrinsic defects in specific ISG induction. We identify a set of ISGs for consideration as latency restriction factors whose expression and function could possibly mitigate establishing latent HIV infection.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12977-022-00599-z","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T13:05:05Z","timestamp":1657285505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Innate immune regulation in HIV latency models"],"prefix":"10.1186","volume":"19","author":[{"given":"Rebecca M.","family":"Olson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Gornalusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne S.","family":"Whitmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Newhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tisoncik-Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ochsenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Hladik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Michael","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"599_CR1","unstructured":"UNAIDS. Global HIV & AIDS statistics\u2014fact sheet. Joint United Nations Programme on HIV\/AIDS (UNAIDS); 2021."},{"issue":"1","key":"599_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","volume":"23","author":"Y Kim","year":"2018","unstructured":"Kim Y, Anderson JL, Lewin SR. Getting the \u201cKill\u201d into \u201cShock and Kill\u201d: strategies to eliminate latent HIV. Cell Host Microbe. 2018;23(1):14\u201326.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"599_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/cells9010254","volume":"9","author":"X Yin","year":"2020","unstructured":"Yin X, Langer S, Zhang Z, Herbert KM, Yoh S, Konig R, et al. Sensor sensibility-HIV-1 and the innate immune response. Cells. 2020;9(1):254.","journal-title":"Cells"},{"issue":"6","key":"599_CR4","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/ni.3157","volume":"16","author":"M Altfeld","year":"2015","unstructured":"Altfeld M, Gale M Jr. Innate immunity against HIV-1 infection. Nat Immunol. 2015;16(6):554\u201362.","journal-title":"Nat Immunol"},{"issue":"6148","key":"599_CR5","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1126\/science.1240933","volume":"341","author":"D Gao","year":"2013","unstructured":"Gao D, Wu J, Wu YT, Du F, Aroh C, Yan N, et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science. 2013;341(6148):903\u20136.","journal-title":"Science"},{"issue":"48","key":"599_CR6","doi-asserted-by":"publisher","first-page":"E4571","DOI":"10.1073\/pnas.1311669110","volume":"110","author":"MR Jakobsen","year":"2013","unstructured":"Jakobsen MR, Bak RO, Andersen A, Berg RK, Jensen SB, Tengchuan J, et al. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc Natl Acad Sci U S A. 2013;110(48):E4571\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"599_CR7","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.4049\/jimmunol.176.5.2888","volume":"176","author":"E Schlaepfer","year":"2006","unstructured":"Schlaepfer E, Audige A, Joller H, Speck RF. TLR7\/8 triggering exerts opposing effects in acute versus latent HIV infection. J Immunol. 2006;176(5):2888\u201395.","journal-title":"J Immunol"},{"issue":"1","key":"599_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41467-019-13837-4","volume":"11","author":"HZ Meas","year":"2020","unstructured":"Meas HZ, Haug M, Beckwith MS, Louet C, Ryan L, Hu Z, et al. Sensing of HIV-1 by TLR8 activates human T cells and reverses latency. Nat Commun. 2020;11(1):147.","journal-title":"Nat Commun"},{"key":"599_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cytogfr.2018.03.001","volume":"40","author":"M Stunnenberg","year":"2018","unstructured":"Stunnenberg M, Geijtenbeek TBH, Gringhuis SI. DDX3 in HIV-1 infection and sensing: a paradox. Cytokine Growth F R. 2018;40:32\u20139.","journal-title":"Cytokine Growth F R"},{"issue":"1","key":"599_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029291","volume":"7","author":"RK Berg","year":"2012","unstructured":"Berg RK, Melchjorsen J, Rintahaka J, Diget E, Soby S, Horan KA, et al. Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA. PLoS ONE. 2012;7(1): e29291.","journal-title":"PLoS ONE"},{"issue":"7","key":"599_CR11","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nm.4124","volume":"22","author":"P Li","year":"2016","unstructured":"Li P, Kaiser P, Lampiris HW, Kim P, Yukl SA, Havlir DV, et al. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation. Nat Med. 2016;22(7):807\u201311.","journal-title":"Nat Med"},{"issue":"6","key":"599_CR12","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1128\/JVI.05738-11","volume":"86","author":"S Jensen","year":"2012","unstructured":"Jensen S, Thomsen AR. Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J Virol. 2012;86(6):2900\u201310.","journal-title":"J Virol"},{"key":"599_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00856-20","author":"AR Harrison","year":"2020","unstructured":"Harrison AR, Moseley GW. The dynamic interface of viruses with STATs. J Virol. 2020. https:\/\/doi.org\/10.1128\/JVI.00856-20.","journal-title":"J Virol"},{"issue":"1","key":"599_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41467-020-14377-y","volume":"11","author":"H Yang","year":"2020","unstructured":"Yang H, Ito F, Wolfe AD, Li S, Mohammadzadeh N, Love RP, et al. Understanding the structural basis of HIV-1 restriction by the full length double-domain APOBEC3G. Nat Commun. 2020;11(1):632.","journal-title":"Nat Commun"},{"issue":"5","key":"599_CR15","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1128\/JVI.01531-10","volume":"85","author":"J Lu","year":"2011","unstructured":"Lu J, Pan Q, Rong L, He W, Liu SL, Liang C. The IFITM proteins inhibit HIV-1 infection. J Virol. 2011;85(5):2126\u201337.","journal-title":"J Virol"},{"issue":"7472","key":"599_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12542","volume":"502","author":"C Goujon","year":"2013","unstructured":"Goujon C, Moncorge O, Bauby H, Doyle T, Ward CC, Schaller T, et al. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature. 2013;502(7472):559\u201362.","journal-title":"Nature"},{"issue":"7472","key":"599_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nature12653","volume":"502","author":"M Kane","year":"2013","unstructured":"Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, Wilson SJ, et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature. 2013;502(7472):563\u20136.","journal-title":"Nature"},{"issue":"5","key":"599_CR18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1073\/pnas.0510518103","volume":"103","author":"A Okumura","year":"2006","unstructured":"Okumura A, Lu G, Pitha-Rowe I, Pitha PM. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A. 2006;103(5):1440\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"599_CR19","doi-asserted-by":"publisher","first-page":"18097","DOI":"10.1073\/pnas.1113694108","volume":"108","author":"RA Liberatore","year":"2011","unstructured":"Liberatore RA, Bieniasz PD. Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo. Proc Natl Acad Sci U S A. 2011;108(44):18097\u2013101.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"599_CR20","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s00018-017-2520-2","volume":"74","author":"N Raftery","year":"2017","unstructured":"Raftery N, Stevenson NJ. Advances in anti-viral immune defence: revealing the importance of the IFN JAK\/STAT pathway. Cell Mol Life Sci. 2017;74(14):2525\u201335.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"599_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/jir.2010.0127","volume":"31","author":"KA Fitzgerald","year":"2011","unstructured":"Fitzgerald KA. The interferon inducible gene: Viperin. J Interferon Cytokine Res. 2011;31(1):131\u20135.","journal-title":"J Interferon Cytokine Res"},{"issue":"5","key":"599_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/v12050495","volume":"12","author":"R Nchioua","year":"2020","unstructured":"Nchioua R, Bosso M, Kmiec D, Kirchhoff F. Cellular factors targeting HIV-1 transcription and viral RNA transcripts. Viruses. 2020;12(5):495.","journal-title":"Viruses"},{"key":"599_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2017.04.004","volume":"37","author":"TS Sandstrom","year":"2017","unstructured":"Sandstrom TS, Ranganath N, Angel JB. Impairment of the type I interferon response by HIV-1: potential targets for HIV eradication. Cytokine Growth F R. 2017;37:1\u201316.","journal-title":"Cytokine Growth F R"},{"issue":"6","key":"599_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.chom.2008.04.008","volume":"3","author":"MH Malim","year":"2008","unstructured":"Malim MH, Emerman M. HIV-1 accessory proteins\u2013ensuring viral survival in a hostile environment. Cell Host Microbe. 2008;3(6):388\u201398.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"599_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056527","volume":"8","author":"GA Hardy","year":"2013","unstructured":"Hardy GA, Sieg S, Rodriguez B, Anthony D, Asaad R, Jiang W, et al. Interferon-alpha is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers. PLoS ONE. 2013;8(2): e56527.","journal-title":"PLoS ONE"},{"issue":"7","key":"599_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrmicro3449","volume":"13","author":"T Doyle","year":"2015","unstructured":"Doyle T, Goujon C, Malim MH. HIV-1 and interferons: who\u2019s interfering with whom? Nat Rev Microbiol. 2015;13(7):403\u201313.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"599_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008151","volume":"16","author":"RM Van der Sluis","year":"2020","unstructured":"Van der Sluis RM, Zerbato JM, Rhodes JW, Pascoe RD, Solomon A, Kumar NA, et al. Diverse effects of interferon alpha on the establishment and reversal of HIV latency. Plos Pathog. 2020;16(2): e1008151.","journal-title":"Plos Pathog"},{"key":"599_CR28","doi-asserted-by":"crossref","unstructured":"Cheng L, Yu H, Li G, Li F, Ma J, Li J, et al. Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection. JCI Insight. 2017;2(12).","DOI":"10.1172\/jci.insight.94366"},{"issue":"4","key":"599_CR29","doi-asserted-by":"publisher","first-page":"E590","DOI":"10.1073\/pnas.1620144114","volume":"114","author":"SS Iyer","year":"2017","unstructured":"Iyer SS, Bibollet-Ruche F, Sherrill-Mix S, Learn GH, Plenderleith L, Smith AG, et al. Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness. Proc Natl Acad Sci U S A. 2017;114(4):E590\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"599_CR30","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1038\/s41598-020-59596-x","volume":"10","author":"M Ashokkumar","year":"2020","unstructured":"Ashokkumar M, Sonawane A, Sperk M, Tripathy SP, Neogi U, Hanna LE. In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha. Sci Rep. 2020;10(1):2747.","journal-title":"Sci Rep"},{"issue":"7511","key":"599_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nature13554","volume":"511","author":"NG Sandler","year":"2014","unstructured":"Sandler NG, Bosinger SE, Estes JD, Zhu RT, Tharp GK, Boritz E, et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature. 2014;511(7511):601\u20135.","journal-title":"Nature"},{"issue":"1","key":"599_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11904-014-0244-6","volume":"12","author":"SE Bosinger","year":"2015","unstructured":"Bosinger SE, Utay NS. Type I interferon: understanding its role in HIV pathogenesis and therapy. Curr HIV\/AIDS Rep. 2015;12(1):41\u201353.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"599_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1172\/JCI89488","volume":"127","author":"A Zhen","year":"2017","unstructured":"Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127(1):260\u20138.","journal-title":"J Clin Invest"},{"issue":"1","key":"599_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1172\/JCI90745","volume":"127","author":"L Cheng","year":"2017","unstructured":"Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127(1):269\u201379.","journal-title":"J Clin Invest"},{"issue":"5","key":"599_CR35","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41591-018-0017-7","volume":"24","author":"LB Cohn","year":"2018","unstructured":"Cohn LB, da Silva IT, Valieris R, Huang AS, Lorenzi JCC, Cohen YZ, et al. Clonal CD4(+) T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation. Nat Med. 2018;24(5):604\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"599_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12977-016-0302-9","volume":"13","author":"N Ranganath","year":"2016","unstructured":"Ranganath N, Sandstrom TS, Fadel S, Cote SC, Angel JB. Type I interferon responses are impaired in latently HIV infected cells. Retrovirology. 2016;13(1):66.","journal-title":"Retrovirology"},{"key":"599_CR37","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01194-19","author":"E Palermo","year":"2019","unstructured":"Palermo E, Acchioni C, Di Carlo D, Zevini A, Muscolini M, Ferrari M, et al. Activation of latent HIV-1 T cell reservoirs with a combination of innate immune and epigenetic regulators. J Virol. 2019. https:\/\/doi.org\/10.1128\/JVI.01194-19.","journal-title":"J Virol"},{"issue":"8","key":"599_CR38","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","volume":"22","author":"A Jordan","year":"2003","unstructured":"Jordan A, Bisgrove D, Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 2003;22(8):1868\u201377.","journal-title":"EMBO J"},{"issue":"7","key":"599_CR39","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1073\/pnas.86.7.2365","volume":"86","author":"TM Folks","year":"1989","unstructured":"Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, et al. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A. 1989;86(7):2365\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"599_CR40","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1073\/pnas.82.13.4539","volume":"82","author":"T Folks","year":"1985","unstructured":"Folks T, Benn S, Rabson A, Theodore T, Hoggan MD, Martin M, et al. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc Natl Acad Sci U S A. 1985;82(13):4539\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"599_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12977-019-0494-x","volume":"16","author":"S Telwatte","year":"2019","unstructured":"Telwatte S, Moron-Lopez S, Aran D, Kim P, Hsieh C, Joshi S, et al. Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency. Retrovirology. 2019;16(1):32.","journal-title":"Retrovirology"},{"issue":"1","key":"599_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-016-0324-3","volume":"14","author":"J Symons","year":"2017","unstructured":"Symons J. HIV integration sites in latently infected cell lines: evidence of ongoing replication. Retroviriology. 2017;14(1):1\u201311.","journal-title":"Retroviriology."},{"issue":"7\u20138","key":"599_CR43","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00335-018-9755-6","volume":"29","author":"R Green","year":"2018","unstructured":"Green R, Ireton RC, Gale M Jr. Interferon-stimulated genes: new platforms and computational approaches. Mamm Genome. 2018;29(7\u20138):593\u2013602.","journal-title":"Mamm Genome"},{"issue":"20","key":"599_CR44","doi-asserted-by":"publisher","first-page":"10395","DOI":"10.1128\/JVI.00849-09","volume":"83","author":"BP Doehle","year":"2009","unstructured":"Doehle BP, Hladik F, McNevin JP, McElrath MJ, Gale M Jr. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J Virol. 2009;83(20):10395\u2013405.","journal-title":"J Virol"},{"issue":"7203","key":"599_CR45","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature07106","volume":"454","author":"T Saito","year":"2008","unstructured":"Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature. 2008;454(7203):523\u20137.","journal-title":"Nature"},{"issue":"16","key":"599_CR46","doi-asserted-by":"publisher","first-page":"8367","DOI":"10.1128\/JVI.00423-12","volume":"86","author":"BP Doehle","year":"2012","unstructured":"Doehle BP, Chang K, Rustagi A, McNevin J, McElrath MJ, Gale M Jr. Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism. J Virol. 2012;86(16):8367\u201374.","journal-title":"J Virol"},{"issue":"1","key":"599_CR47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.virol.2007.10.042","volume":"373","author":"A Okumura","year":"2008","unstructured":"Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, Pitha PM. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology. 2008;373(1):85\u201397.","journal-title":"Virology"},{"issue":"6","key":"599_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","volume":"1","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Rice CM. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol. 2011;1(6):519\u201325.","journal-title":"Curr Opin Virol"},{"issue":"9","key":"599_CR49","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/ijms17091483","volume":"17","author":"XB Ling","year":"2016","unstructured":"Ling XB, Wei HW, Wang J, Kong YQ, Wu YY, Guo JL, et al. Mammalian metallothionein-2A and oxidative stress. Int J Mol Sci. 2016;17(9):1483.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"599_CR50","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/PL00000801","volume":"58","author":"BT Kile","year":"2001","unstructured":"Kile BT, Alexander WS. The suppressors of cytokine signalling (SOCS). Cell Mol Life Sci. 2001;58(11):1627\u201335.","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"599_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005850","volume":"12","author":"YJ Kim","year":"2016","unstructured":"Kim YJ, Kim ET, Kim YE, Lee MK, Kwon KM, Kim KI, et al. Consecutive inhibition of ISG15 expression and ISGylation by cytomegalovirus regulators. Plos Pathog. 2016;12(8): e1005850.","journal-title":"Plos Pathog"},{"issue":"17","key":"599_CR52","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1128\/JVI.78.17.8983-8993.2004","volume":"78","author":"B Dong","year":"2004","unstructured":"Dong B, Zhou Q, Zhao J, Zhou A, Harty RN, Bose S, et al. Phospholipid scramblase 1 potentiates the antiviral activity of interferon. J Virol. 2004;78(17):8983\u201393.","journal-title":"J Virol"},{"issue":"8","key":"599_CR53","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1128\/JVI.03478-12","volume":"87","author":"MS Dahabieh","year":"2013","unstructured":"Dahabieh MS, Ooms M, Simon V, Sadowski I. A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection. J Virol. 2013;87(8):4716\u201327.","journal-title":"J Virol"},{"issue":"8","key":"599_CR54","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3390\/v13081472","volume":"13","author":"GG Gornalusse","year":"2021","unstructured":"Gornalusse GG, Vojtech LN, Levy CN, Hughes SM, Kim Y, Valdez R, et al. Buprenorphine increases HIV-1 infection in vitro but does not reactivate HIV-1 from latency. Viruses. 2021;13(8):1472.","journal-title":"Viruses"},{"issue":"1","key":"599_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030176","volume":"7","author":"KG Lassen","year":"2012","unstructured":"Lassen KG, Hebbeler AM, Bhattacharyya D, Lobritz MA, Greene WC. A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs. PLoS ONE. 2012;7(1): e30176.","journal-title":"PLoS ONE"},{"issue":"13","key":"599_CR56","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1182\/blood-2007-06-097907","volume":"110","author":"S Saleh","year":"2007","unstructured":"Saleh S, Solomon A, Wightman F, Xhilaga M, Cameron PU, Lewin SR. CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. Blood. 2007;110(13):4161\u20134.","journal-title":"Blood"},{"issue":"39","key":"599_CR57","doi-asserted-by":"publisher","first-page":"16934","DOI":"10.1073\/pnas.1002894107","volume":"107","author":"PU Cameron","year":"2010","unstructured":"Cameron PU, Saleh S, Sallmann G, Solomon A, Wightman F, Evans VA, et al. Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton. Proc Natl Acad Sci U S A. 2010;107(39):16934\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"599_CR58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1182\/blood-2008-07-168393","volume":"113","author":"A Bosque","year":"2009","unstructured":"Bosque A, Planelles V. Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood. 2009;113(1):58\u201365.","journal-title":"Blood"},{"issue":"1","key":"599_CR59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/imr.12519","volume":"276","author":"LP Andrews","year":"2017","unstructured":"Andrews LP, Marciscano AE, Drake CG, Vignali DA. LAG3 (CD223) as a cancer immunotherapy target. Immunol Rev. 2017;276(1):80\u201396.","journal-title":"Immunol Rev"},{"issue":"2","key":"599_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007619","volume":"15","author":"M Pardons","year":"2019","unstructured":"Pardons M, Baxter AE, Massanella M, Pagliuzza A, Fromentin R, Dufour C, et al. Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection. Plos Pathog. 2019;15(2): e1007619.","journal-title":"Plos Pathog"},{"issue":"7","key":"599_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005761","volume":"12","author":"R Fromentin","year":"2016","unstructured":"Fromentin R, Bakeman W, Lawani MB, Khoury G, Hartogensis W, DaFonseca S, et al. CD4+ T cells expressing PD-1, TIGIT and LAG-3 contribute to HIV persistence during ART. Plos Pathog. 2016;12(7): e1005761.","journal-title":"Plos Pathog"},{"key":"599_CR62","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.virusres.2018.11.012","volume":"260","author":"M Okamoto","year":"2019","unstructured":"Okamoto M, Hidaka A, Toyama M, Baba M. Galectin-3 is involved in HIV-1 expression through NF-kappaB activation and associated with Tat in latently infected cells. Virus Res. 2019;260:86\u201393.","journal-title":"Virus Res"},{"key":"599_CR63","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.56185","author":"J Ahel","year":"2020","unstructured":"Ahel J, Lehner A, Vogel A, Schleiffer A, Meinhart A, Haselbach D, et al. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism. Elife. 2020. https:\/\/doi.org\/10.7554\/eLife.56185.","journal-title":"Elife"},{"issue":"1","key":"599_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S2055-6640(20)30275-2","volume":"5","author":"J Vanhamel","year":"2019","unstructured":"Vanhamel J, Bruggemans A, Debyser Z. Establishment of HIV latent reservoirs: what do we really know? J Virus Erad. 2019;5(1):3\u20139.","journal-title":"J Virus Erad"},{"key":"599_CR65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1196\/annals.1299.005","volume":"1010","author":"G Marsili","year":"2003","unstructured":"Marsili G, Borsetti A, Sgarbanti M, Remoli AL, Ridolfi B, Stellacci E, et al. On the role of interferon regulatory factors in HIV-1 replication. Ann N Y Acad Sci. 2003;1010:29\u201342.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"599_CR66","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007096","volume":"1","author":"RF Siliciano","year":"2011","unstructured":"Siliciano RF, Greene WC. HIV latency. Cold Spring Harb Perspect Med. 2011;1(1): a007096.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"599_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113908","volume":"9","author":"CL Kleinman","year":"2014","unstructured":"Kleinman CL, Doria M, Orecchini E, Giuliani E, Galardi S, De Jay N, et al. HIV-1 infection causes a down-regulation of genes involved in ribosome biogenesis. PLoS ONE. 2014;9(12): e113908.","journal-title":"PLoS ONE"},{"issue":"1","key":"599_CR68","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri3344","volume":"13","author":"MS Diamond","year":"2013","unstructured":"Diamond MS, Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol. 2013;13(1):46\u201357.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"599_CR69","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3892\/ijo.2016.3387","volume":"48","author":"KM Goudarzi","year":"2016","unstructured":"Goudarzi KM, Lindstrom MS. Role of ribosomal protein mutations in tumor development (Review). Int J Oncol. 2016;48(4):1313\u201324.","journal-title":"Int J Oncol"},{"issue":"5","key":"599_CR70","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1038\/ncb0502-e131","volume":"4","author":"E Shaulian","year":"2002","unstructured":"Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4(5):E131\u20136.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"599_CR71","doi-asserted-by":"publisher","first-page":"15169","DOI":"10.1038\/s41598-020-71669-5","volume":"10","author":"T Tanaka","year":"2020","unstructured":"Tanaka T, Warner BM, Odani T, Ji Y, Mo YQ, Nakamura H, et al. LAMP3 induces apoptosis and autoantigen release in Sjogren\u2019s syndrome patients. Sci Rep. 2020;10(1):15169.","journal-title":"Sci Rep"},{"issue":"1","key":"599_CR72","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.celrep.2018.09.020","volume":"25","author":"T Bradley","year":"2018","unstructured":"Bradley T, Ferrari G, Haynes BF, Margolis DM, Browne EP. Single-cell analysis of quiescent HIV infection reveals host transcriptional profiles that regulate proviral latency. Cell Rep. 2018;25(1):107\u201317.","journal-title":"Cell Rep"},{"key":"599_CR73","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ebiom.2016.11.024","volume":"14","author":"RD Astronomo","year":"2016","unstructured":"Astronomo RD, Santra S, Ballweber-Fleming L, Westerberg KG, Mach L, Hensley-McBain T, et al. Neutralization takes precedence over IgG or IgA isotype-related functions in mucosal HIV-1 antibody-mediated protection. EBioMedicine. 2016;14:97\u2013111.","journal-title":"EBioMedicine"},{"issue":"12","key":"599_CR74","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1089\/aid.2015.0074","volume":"31","author":"MO Alberti","year":"2015","unstructured":"Alberti MO, Jones JJ, Miglietta R, Ding H, Bakshi RK, Edmonds TG, et al. Optimized replicating Renilla luciferase reporter HIV-1 utilizing novel internal ribosome entry site elements for native Nef expression and function. AIDS Res Hum Retroviruses. 2015;31(12):1278\u201396.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"599_CR75","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.celrep.2017.06.087","volume":"20","author":"M Cavrois","year":"2017","unstructured":"Cavrois M, Banerjee T, Mukherjee G, Raman N, Hussien R, Rodriguez BA, et al. Mass cytometric analysis of HIV entry, replication, and remodeling in tissue CD4+ T cells. Cell Rep. 2017;20(4):984\u201398.","journal-title":"Cell Rep"},{"key":"599_CR76","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00484-18","author":"J Pr\u00e9vost","year":"2018","unstructured":"Pr\u00e9vost J, Richard J, Medjahed H, Alexander A, Jones J, Kappes JC, et al. Incomplete downregulation of CD4 expression affects HIV-1 env conformation and antibody-dependent cellular cytotoxicity responses. J Virol. 2018. https:\/\/doi.org\/10.1128\/JVI.00484-18.","journal-title":"J Virol"},{"issue":"12","key":"599_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008161","volume":"15","author":"JD Ventura","year":"2019","unstructured":"Ventura JD, Beloor J, Allen E, Zhang T, Haugh KA, Uchil PD, et al. Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice. PLoS Pathog. 2019;15(12): e1008161.","journal-title":"PLoS Pathog"},{"issue":"21","key":"599_CR78","doi-asserted-by":"publisher","first-page":"11056","DOI":"10.1128\/JVI.01964-15","volume":"89","author":"A Kell","year":"2015","unstructured":"Kell A, Stoddard M, Li H, Marcotrigiano J, Shaw GM, Gale M Jr. Pathogen-associated molecular pattern recognition of hepatitis C virus transmitted\/founder variants by RIG-I is dependent on U-core length. J Virol. 2015;89(21):11056\u201368.","journal-title":"J Virol"},{"issue":"2","key":"599_CR79","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ymeth.2012.05.011","volume":"59","author":"A Rustagi","year":"2013","unstructured":"Rustagi A, Doehle BP, McElrath MJ, Gale M Jr. Two new monoclonal antibodies for biochemical and flow cytometric analyses of human interferon regulatory factor-3 activation, turnover, and depletion. Methods. 2013;59(2):225\u201332.","journal-title":"Methods"},{"issue":"1","key":"599_CR80","first-page":"10","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal. 2011;17(1):10.","journal-title":"EMBnetjournal."},{"key":"599_CR81","unstructured":"Andrews S. FastQC: a quality control tool for high throughput sequence data [Online]. 2010."},{"issue":"4","key":"599_CR82","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357\u20139.","journal-title":"Nat Methods"},{"issue":"1","key":"599_CR83","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"2","key":"599_CR84","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166\u20139.","journal-title":"Bioinformatics"},{"issue":"2","key":"599_CR85","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29.","journal-title":"Genome Biol"},{"issue":"7","key":"599_CR86","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"599_CR87","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/wics.147","volume":"3","author":"H Wickham","year":"2011","unstructured":"Wickham H. ggplot2. Wiley Interdiscip Rev Comput Stat. 2011;3(2):180\u20135.","journal-title":"Wiley Interdiscip Rev Comput Stat"},{"issue":"W1","key":"599_CR88","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47(W1):W199\u2013205.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"599_CR89","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57(1):289\u2013300.","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"599_CR90","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"599_CR91","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/bioinformatics\/btm563","volume":"24","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics. 2008;24(5):719\u201320.","journal-title":"Bioinformatics"},{"issue":"4","key":"599_CR92","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer A, Green J, Pollard J Jr, Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30(4):523\u201330.","journal-title":"Bioinformatics"},{"issue":"4","key":"599_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100243","volume":"2","author":"CN Levy","year":"2021","unstructured":"Levy CN, Hughes SM, Roychoudhury P, Reeves DB, Amstuz C, Zhu H, et al. A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir. Cell Rep Med. 2021;2(4): 100243.","journal-title":"Cell Rep Med"},{"key":"599_CR94","doi-asserted-by":"publisher","first-page":"14049","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng GX, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 2017;8:14049.","journal-title":"Nat Commun"},{"issue":"5","key":"599_CR95","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411\u201320.","journal-title":"Nat Biotechnol"},{"key":"599_CR96","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak G, McDavid A, Yajima M, Deng J, Gersuk V, Shalek AK, et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 2015;16:278.","journal-title":"Genome Biol"},{"issue":"4","key":"599_CR97","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"599_CR98","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41592-019-0535-3","volume":"16","author":"HA Pliner","year":"2019","unstructured":"Pliner HA, Shendure J, Trapnell C. Supervised classification enables rapid annotation of cell atlases. Nat Methods. 2019;16(10):983\u20136.","journal-title":"Nat Methods"},{"issue":"1","key":"599_CR99","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1006\/viro.1999.9614","volume":"256","author":"Sylvia L. Anderson","year":"1999","unstructured":"Sylvia L, Anderson Jill M, Carton Jing, Lou Lily, Xing Berish Y, Rubin. Interferon Induced Guanylate Binding Protein-1 (GBP-1) Mediates an Antiviral Effect against Vesicular Stomatitis Virus and Encephalomyocarditis Virus. Virology.\u00a01999;256(1):8\u201314. https:\/\/doi.org\/10.1006\/viro.1999.9614.","journal-title":"Virology"},{"issue":"4","key":"599_CR100","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.chom.2016.02.019","volume":"19","author":"Christian Krapp","year":"2016","unstructured":"Christian, Krapp Dominik, Hotter Ali, Gawanbacht Paul\u00a0J, McLaren Silvia\u00a0F, Kluge Christina\u00a0M, St\u00fcrzel Katharina, Mack Elisabeth, Reith Susanne, Engelhart Angela, Ciuffi Veit, Hornung Daniel, Sauter Amalio, Telenti Frank, Kirchhoff. Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity. Cell Host & Microbe. 2016;19(4):504\u2013514. https:\/\/doi.org\/10.1016\/j.chom.2016.02.019.","journal-title":"Cell Host & Microbe"},{"issue":"1","key":"599_CR101","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.celrep.2015.08.055","volume":"13","author":"Jingyou Yu","year":"2015","unstructured":"Jingyou, Yu Minghua, Li Jordan, Wilkins Shilei, Ding Talia\u00a0H, Swartz Anthony\u00a0M, Esposito Yi-Min, Zheng Eric\u00a0O, Freed Chen, Liang Benjamin\u00a0K, Chen Shan-Lu, Liu. IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein. Cell Reports. 2015;13(1):145-156. https:\/\/doi.org\/10.1016\/j.celrep.2015.08.055.","journal-title":"Cell Reports"},{"issue":"4","key":"599_CR102","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","volume":"36","author":"Stark JamesE GeorgeR","year":"2012","unstructured":"George\u00a0R, Stark James\u00a0E, Darnell.\u00a0The JAK-STAT Pathway at Twenty. Immunity.2012; 36(4):503-514. https:\/\/doi.org\/10.1016\/j.immuni.2012.03.013.","journal-title":"The JAK-STAT Pathway at Twenty. Immunity."}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-022-00599-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12977-022-00599-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-022-00599-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T20:14:44Z","timestamp":1727554484000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-022-00599-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1186\/s12977-022-00599-z","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}